Streetbeat News

Regulatory

VWAGY

Volkswagen AG is facing challenges with its new Scout brand due to opposition from U.S. franchise dealers over its direct-to-consumer sales strategy. Despite past scandals and slow BEV adoption, VW aims for growth through strategic investments and cost-cutting measures.

Portfolio Pulse from

November 11, 2024 | 10:30 pm

HUMA

Humacyte (HUMA) is under scrutiny following an FDA report highlighting issues with its facilities, which contradicts previous assurances given by the company's COO to investors.

Portfolio Pulse from

November 11, 2024 | 10:00 pm

MYGN

Levi & Korsinsky has initiated an investigation into Myriad Genetics, Inc. for potential securities fraud. This follows UnitedHealth Group's decision to stop covering Myriad's GeneSight test starting January 2025.

Portfolio Pulse from

November 11, 2024 | 10:00 pm

GFR

Greenfire Resources Ltd. has announced the filing of a new shareholder protection rights plan with the Toronto Stock Exchange. The TSX has deferred its consideration of the plan until it is assured that no intervention will occur from the securities commission.

Portfolio Pulse from

November 11, 2024 | 9:45 pm

ZVRA

Zevra Therapeutics will present data at the 53rd Child Neurology Society Annual Meeting, highlighting the relevance of the Swallow Domain in the Niemann-Pick Disease Type C Clinical Severity Scale. The study shows that changes in the NPCCSS swallow score reflect actual improvements or worsening in a patient's swallowing function.

Portfolio Pulse from

November 11, 2024 | 9:45 pm

PAL

Levi & Korsinsky has initiated an investigation into Proficient Auto Logistics, Inc. (NYSE:PAL) for potential violations of federal securities laws. This follows a report by PAL on October 16, 2024, regarding its expected operating and financial metrics for Q3 2024.

Portfolio Pulse from

November 11, 2024 | 9:45 pm

TSM

Taiwan Semiconductor Manufacturing Company (TSMC) stock fell due to the U.S. government's decision to restrict the company's AI chips from being exported to China.

Portfolio Pulse from

November 11, 2024 | 9:30 pm

JNJ

Johnson & Johnson's investigational therapy, nipocalimab, has been granted Breakthrough Therapy Designation by the FDA for treating moderate-to-severe Sjögren's disease. This is the first therapy to receive such a designation for this condition, supported by positive Phase 2 study results.

Portfolio Pulse from

November 11, 2024 | 9:30 pm

ECO

Okeanis Eco Tankers Corp. has released its 2023 ESG Report, adhering to GRI 2021 Standards and SASB for Marine Transportation.

Portfolio Pulse from

November 11, 2024 | 9:30 pm

TT

Trane Technologies is set to emphasize the importance of decarbonization and sustainable climate policies at COP29, focusing on electrified heating and cooling solutions.

Portfolio Pulse from

November 11, 2024 | 9:30 pm